IPCA Laboratories Limited

Web: ipca.com NSE: IPCALAB BSE: 524494 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

1961 5(0%)

Near 52W High of 1994

Volume

3L as on 03, Sep

Open

1,468

High

1,747

Low

1,686

1,956

VWAP

1,947

52 Week High

1,994

52 Week Low

1,252

Viand Research Rating

Quality Score

80/100

Growth Score

68/100

Valuation Score

50/100

Momentum Score

70/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

49,762

No. of Shares

25.4

P/E

59.03

P/B

5.69

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

9.65

ROCE

Profit Growth

Listing Date

08-Feb-95

Promoter Holding

44.72%

FII Holding

10.72%

DII Holding

37.04%

Price Chart

Price Performance

1 Week0%

1 Month13%

3 Months26%

6 Months29%

1 Year46%

YTD40%

Moving Average

5 Day SMA1,965

10 Day SMA1,950

20 Day SMA1,877

30 Day SMA1,836

50 Day SMA1,813

61 Day SMA1,772

80 Day SMA1,729

200 Day SMA1,579

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	2,042	1,971	2,022	2,038
Resistance 2	2,022	1,966	2,001	2,020
Resistance 1	1,989	1,961	1,989	1,986
Pivot Point	1,969	1,956	1,969	1,967
Support 1	1,936	1,952	1,949	1,933
Support 2	1,916	1,947	1,936	1,915
Support 3	1,884	1,942	1,916	1,881

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 44.72%	(0.01) 44.72%	(0.01) 44.72%	(0.01) 44.72%	(0.01) 44.72%	(0.01) 44.72%	(-1.61) 44.72%	(0.01) 46.30%	(0.01) 46.30%	(0.01) 46.30%	(0.01) 46.29%	(0.01) 46.29%	(0.01) 46.29%	(0.01) 46.29%	(0.01) 46.29%	(0.01) 46.29%	(0.01) 46.29%	(0.01) 46.29%	(0.01) 46.29%	(0.01) 46.29%
FIIs	(0.11) 10.72%	(0.01) 10.63%	(0.21) 10.62%	(-0.31) 10.42%	(-0.11) 10.67%	(-0.31) 10.75%	(0.21) 11.06%	(0.01) 10.83%	(0.31) 10.85%	(0.21) 10.51%	(0.41) 10.27%	(-0.21) 9.86%	(-0.51) 10.05%	(0.11) 10.58%	(-0.11) 10.46%	(0.01) 10.57%	(-0.41) 10.61%	(-1.31) 11.02%	(-6.11) 12.34%	(0.01) 18.46%
DIIs	(-0.11) 37.04%	(0.11) 37.13%	(0.51) 36.99%	(0.61) 36.45%	(0.21) 35.88%	(0.41) 35.73%	(1.51) 35.36%	(0.41) 33.90%	(-0.61) 33.46%	(-0.11) 34.05%	(-0.51) 34.19%	(-0.11) 34.72%	(1.11) 34.86%	(0.01) 33.74%	(0.31) 33.71%	(0.01) 33.46%	(0.81) 33.49%	(2.71) 32.70%	(4.81) 30.02%	(0.01) 25.24%
Government	0.32%	0.32%	0.32%	0.32%	0.32%	0.32%	0.32%	0.32%	0.32%	0.32%	0.32%	0.32%	0.32%	0.32%	0.32%	0.32%	0.24%	0.24%	0.24%	0.22%
Public	7.19%	7.21%	7.33%	8.09%	8.41%	8.45%	8.53%	8.64%	9.07%	8.82%	8.93%	8.80%	8.46%	9.06%	9.22%	9.34%	9.37%	9.75%	11.11%	9.80%
No. of Shareholders	82,060	82,184	77,673	82,870	85,582	88,306	90,189	82,975	84,753	81,165	82,809	95,930	99,889	110,296	108,177	111,043	110,818	115,335	106,779	95,239

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	2788	2388	2392	2556	2309	2247	2245	2355	2093	2033	2053	2034	1585	1512	1546	1601	1586	1289	1430	1544	1566
Sales Growth % (YoY)	20.8%	6.3%	6.6%	8.6%	10.3%	10.5%	9.4%	15.8%	32%	34.5%	32.8%	27%	0%	17.3%	8.1%	3.7%	1.3%	15.6%	1.5%	13.5%	2%
Sales Growth % (QoQ)	16.8%	-0.2%	-6.4%	10.7%	2.8%	0.1%	-4.7%	12.5%	3%	-1%	0.9%	28.3%	4.8%	-2.2%	-3.4%	0.9%	23%	-9.9%	-7.4%	-1.4%	-
Expenses	2119	1905	1859	2012	1892	1818	1782	1913	1700	1711	1722	1673	1278	1331	1330	1341	1317	1070	1123	1184	1152
Operating Profit	670	484	533	545	416	429	463	441	393	322	331	361	308	181	216	260	269	219	308	360	414
OPM %	24	20	22	21	18	19	21	19	19	16	16	18	19	12	14	16	17	17	22	23	26
Other Income	25	48	38	-30	33	-179	20	26	21	-118	91	-1	45	36	31	36	22	15	12	18	21
Interest	12	20	18	20	19	22	17	23	24	29	33	44	31	18	11	9	7	3	1	1	2
Depreciation	111	107	108	103	100	100	98	100	99	98	100	90	69	70	67	64	62	61	59	57	56
Profit before tax	572	404	446	392	331	128	368	345	290	77	289	225	252	129	169	223	223	170	260	320	377
Tax %	26	24	18	28	29	49	25	29	31	96	23	39	34	37	32	35	33	17	22	21	19
Net Profit	424	307	364	281	233	64	276	246	199	1	221	136	164	78	110	146	145	132	198	252	307
Net Profit Growth % (QoQ)	38.1%	-15.7%	29.5%	20.6%	264.1%	-76.8%	12.2%	23.6%	19800%	-99.5%	62.5%	-17.1%	110.3%	-29.1%	-24.7%	0.7%	9.8%	-33.3%	-21.4%	-17.9%	-
Net Profit Growth % (YoY)	82%	379.7%	31.9%	14.2%	17.1%	6300%	24.9%	80.9%	21.3%	-98.7%	100.9%	-6.8%	13.1%	-40.9%	-44.4%	-42.1%	-52.8%	-	-	-	-
TTM Net Profit	1376	1185	942	854	819	785	722	667	557	522	599	488	498	479	533	621	727	889	757	559	0
EPS in Rs	15.84	11.79	12.86	11.14	9.19	2.67	9.78	9.05	7.58	2.35	7.09	5.72	6.42	3.02	4.25	5.67	5.64	5.13	7.74	9.86	12.09

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	9599	8897	7662	6204	5797	5395	4619	3746	3258	3156	2867	3144	3282	2813
Sales Growth %	7.9%	16.1%	23.5%	7%	7.4%	16.8%	23.3%	15%	3.2%	10.1%	-8.8%	-4.2%	16.7%	19.3%
Expenses	7609	7166	6338	5272	4472	3843	3715	3051	2803	2705	2573	2604	2539	2248
Operating Profit	1990	1731	1324	932	1325	1552	904	695	455	451	294	541	743	565
OPM %	21	19	17	15	23	29	20	19	14	14	10	17	23	20
Other Income	80	-114	17	123	54	59	65	56	41	11	21	32	21	13
Interest	79	88	141	48	11	12	20	22	28	27	35	32	30	36
Depreciation	418	398	357	262	232	209	210	182	178	173	163	180	103	87
Profit before tax	1573	1131	843	745	1136	1389	739	546	291	262	117	361	631	454
Tax %	24	30	37	34	20	17	18	19	18	26	18	28	24	29
Net Profit	1184	785	523	479	890	1141	604	442	239	195	93	254	479	324
Net Profit Growth %	50.8%	50.1%	9.2%	-46.2%	-22%	88.9%	36.7%	84.9%	22.6%	109.7%	-63.4%	-47%	47.8%	-
EPS in Rs	44.98	29.08	21.57	18.58	34.85	44.94	23.99	17.6	9.49	7.71	3.69	10.07	18.96	12.82
Dividend Payout %	0	14	19	22	11	9	10	9	5	6	0	5	13	16

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	1142	1321	945	806	856	1090	570	501	341	282	709	468	522	389
Cash from Investing Activity	-247	-870	-1215	-725	-851	-521	-509	-165	-135	-149	-218	-689	-369	-260
Cash from Financing Activity	-754	-283	-553	507	427	-306	-137	-183	-130	-159	-462	251	-136	-83
Net Cash Flow	142	169	-823	588	432	264	-76	153	75	-26	29	29	18	46

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	25	25	25	25	25	25	25	25	25	25	25	25	25	25	25	25
Reserves	8038	7402	6923	6675	6307	5817	5467	4676	3602	3097	2663	2430	2234	2183	1934	1529
Borrowings	809	1279	1363	1202	1438	1481	807	265	501	465	628	716	867	935	603	617
Other Liabilities	3477	3557	3432	3521	3326	1300	1338	1099	1130	961	799	788	765	669	648	526
Total Liabilities	12350	12263	11744	11424	11097	8623	7637	6066	5258	4549	4116	3960	3892	3812	3211	2697
Fixed Assets	4627	4371	4267	4523	4554	2751	2418	2072	2059	1940	1953	1983	2014	1800	1354	1104
CWIP	773	777	622	485	343	140	306	235	133	66	73	95	129	267	165	129
Investments	844	1203	980	944	862	626	989	505	310	120	87	136	26	16	9	9
Other Assets	6106	5912	5875	5472	5339	5105	3924	3254	2756	2422	2003	1746	1723	1729	1683	1455
Total Assets	12350	12263	11744	11424	11097	8623	7637	6066	5258	4549	4116	3960	3892	3812	3211	2697

Delivery

Delivery Data: IPCALAB

#	Date	1616 24% 2002	Value (Cr)	Q/T 17	Del 47	Del 129
1	4-Sep	1965	16	9	57	9
2	3-Sep	1956	58	12	53	31
3	2-Sep	1956	32	7	50	16
4	1-Sep	1988	43	9	55	24
5	31-Aug	1975	70	17	66	47
6	28-Aug	1950	54	11	53	28
7	27-Aug	1960	24	8	54	13
8	26-Aug	1952	89	13	44	39
9	25-Aug	1928	83	14	46	38
10	24-Aug	1920	53	14	56	30
11	21-Aug	1911	37	11	49	18
12	20-Aug	1900	45	13	53	24
13	19-Aug	1904	143	11	43	62
14	18-Aug	1882	152	18	28	43
15	17-Aug	1885	1305	21	19	253
16	14-Aug	1734	68	14	47	32
17	13-Aug	1796	337	18	18	61
18	12-Aug	1767	26	11	49	13
19	11-Aug	1748	40	10	43	17
20	10-Aug	1686	41	10	55	22
21	7-Aug	1736	14	7	48	7
22	6-Aug	1734	27	11	51	14
23	5-Aug	1765	50	11	52	26
24	4-Aug	1695	38	11	62	23
25	3-Aug	1726	28	7	57	16
26	31-Jul	1748	24	6	53	13
27	30-Jul	1759	25	7	53	13
28	29-Jul	1774	28	9	51	14
29	28-Jul	1789	42	10	47	20
30	27-Jul	1778	21	6	48	10
31	24-Jul	1763	14	8	43	6
32	23-Jul	1771	29	8	55	16
33	22-Jul	1788	34	10	47	16
34	21-Jul	1799	79	16	76	60
35	20-Jul	1839	56	10	53	30
36	17-Jul	1901	30	11	53	16
37	16-Jul	1890	150	29	76	115
38	15-Jul	1878	54	10	49	26
39	14-Jul	1840	44	9	47	21
40	13-Jul	1823	62	13	50	31
41	10-Jul	1788	26	8	58	15
42	9-Jul	1770	17	8	46	8
43	8-Jul	1762	29	8	47	14
44	7-Jul	1793	25	8	60	15
45	6-Jul	1782	70	13	64	45
46	3-Jul	1779	101	9	50	50
47	2-Jul	1719	29	9	60	18
48	1-Jul	1696	38	9	42	16
49	30-Jun	1701	156	18	48	75
50	29-Jun	1647	55	12	50	28

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	49,762c	449c	0.91
03-Sep	49,313c	345c	0.69
01-Sep	49,658c	652c	1.30
31-Aug	50,310c	591c	1.19
26-Aug	49,718c	723c	1.48
25-Aug	48,995c	259c	0.53
24-Aug	48,737c	41c	0.08
21-Aug	48,696c	340c	0.70
19-Aug	48,356c	710c	1.49
18-Aug	47,646c	71c	0.15
17-Aug	47,575c	3,608c	8.21
14-Aug	43,967c	1,921c	4.19
13-Aug	45,888c	1,007c	2.24
12-Aug	44,880c	1,324c	3.04
11-Aug	43,556c	703c	1.64
10-Aug	42,853c	1,116c	2.54
06-Aug	43,970c	713c	1.65
04-Aug	43,257c	647c	1.47
03-Aug	43,904c	292c	0.66
31-Jul	44,195c	644c	1.44
30-Jul	44,840c	337c	0.75
29-Jul	45,177c	145c	0.32
28-Jul	45,033c	355c	0.78
27-Jul	45,388c	685c	1.53
24-Jul	44,703c	0	0

Stock Checklist

Price is above from 52 week high low average: 96%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 260 fund scheme(s) across 33 fund house(s) as of Aug26 · Total value ₹27,311 Cr · 110 increasing / 64 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
HDFC Mutual Fund	26	1.51%	-0.04%	8456.1
Kotak Mahindra Mutual Fund	12	2.39%	+0.01%	5642.4
DSP Mutual Fund	30	1.65%	-0.66%	3731.2
Nippon India Mutual Fund	14	0.85%	+0.03%	2331.5
Axis Mutual Fund	10	1.66%	-0.01%	1816.5
Edelweiss Mutual Fund	18	1.40%	+0.25%	1073.6
HSBC Mutual Fund	6	1.27%	+0.46%	998.6
UTI Mutual Fund	10	0.67%	+0.10%	508.5
Franklin Templeton Mutual Fund	2	1.79%	-0.23%	458.8
quant Mutual Fund	6	1.94%	+2.32%	333.6
Aditya Birla Sun Life Mutual Fund	10	0.66%	-0.06%	325.6
Bandhan Mutual Fund	12	0.73%	+0.13%	314.7
WhiteOak Capital Mutual Fund	8	0.97%	+0.01%	240.5
Mirae Asset Mutual Fund	6	3.15%	-0.09%	210.3
Baroda BNP Paribas Mutual Fund	8	2.48%	+0.26%	196.7
PGIM India Mutual Fund	2	0.82%	+0.06%	180.8
Union Mutual Fund	10	1.62%	+0.50%	154.1
Tata Mutual Fund	8	1.01%	+0.09%	120.3
Motilal Oswal Mutual Fund	8	0.40%	+0.03%	56.6
Bank of India Mutual Fund	2	0.74%	-0.07%	26.2
ITI Mutual Fund	6	0.65%	-	24
ICICI Prudential Mutual Fund	10	0.37%	-0.03%	23.9
Bajaj Finserv Mutual Fund	2	2.34%	-0.09%	17.6
SBI Mutual Fund	4	0.40%	+0.04%	16
Sundaram Mutual Fund	2	0.88%	+0.88%	15.9
The Wealth Company Mutual Fund	2	2.13%	+2.13%	10.3
Trust Mutual Fund	2	1.10%	+0.43%	6.9
LIC Mutual Fund	2	2.96%	-0.04%	5.8
Zerodha Mutual Fund	4	0.29%	-	5.4
Navi Mutual Fund	6	0.55%	+0.04%	4.7
Groww Mutual Fund	6	0.22%	+0.32%	2
Jio BlackRock Mutual Fund	4	0.05%	+0.04%	2
Angel One Mutual Fund	2	0.11%	-	0.1

IPCA Laboratories Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements